TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/13/2026
Back to search
Official data from USPTO
S SONORANT THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000088464893Class
5, 10, 40, 41, 42
Filing
88464893
Registration
6078031
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
03/15/2026
Trademark type
Combined
Nice classes
5, 10, 40, 41, 42
Filing date
06/07/2019
Registration date
06/16/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/16/2020
Last transaction
03/15/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
99
Owner location
Dublin 15, IE
Examiner
LINDEMYER, ANKHI MUKHERJEA
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of of a design of a stylized "S" on the left, with a design of 5 vertical lines that vary in length across the middle of the "S", with the tallest in the middle and the shortest on the outside. The stylized wording "SONORANT THERAPEUTICS" is stacked vertically on the right.
Holders and representatives
Holders
Mallinckrodt Pharmaceuticals Ireland Limited
Representatives
Camille M. Miller Cozen O'Connor
Technical classification
Nice Classes
Class 5Class 10Class 40Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of neurological diseases and disordersnephrotic diseasesendocrine disordersrheumatic disorderscollagen diseasesdermatologic diseases and disordersallergic statesophthalmic diseasesrespiratory diseaseshematologic disordersneoplastic diseasesedematous stategastrointestinal diseaseshepatic diseases and disordersbiliary diseases and disordersrenal disorderscardiovascular and lipid-related diseases and disordersinflammatory and autoimmune diseases and disorders; intravenous analgesics and antipyretics; medical gases for inhalation; bioengineered tissues for surgical implantation
Class 10
Medical apparatus and instruments for use in connection with the administration of gases to patients for medical and therapeutic purposes and accessories and parts thereofmedical and therapeutic gas delivery systems comprised primarily of gas cylindersvalvesregulatorsflow metersdelivery hoses and apparatus and instruments for settingmeasuring and regulating the mixture of medical and therapeutic gases delivered to patients; Therapeutic medical device and accessories and parts thereof for extracting blood from the bodyseparating bloodtreating it extracorporallyreturning it to the body used for extracorporeal photopheresisextracorporeal photo immune therapyextracorporeal photo chemotherapycellular therapies; injection devices incorporating prefilled syringes containing injectable pharmaceuticals for manual injection
Class 40
Custom manufacturing of pharmaceuticals and active pharmaceutical ingredients
Class 41
Educational servicestraining in the fields of pharmaceutical dosing and training in the use and operation of medical devices used to administer nitric oxide to a patient and medical devices used to administer extracorporeal photopheresis to a patient; educational servicesproviding classesseminarsworkshops in the fields of pharmaceuticals and medical devices
Class 42
Scientific research services for medical purposes
Publications
History of USPTO decisions and trademark events.
27 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/13/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/13/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/13/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/13/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/13/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/16/2025
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
11/22/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/12/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
07/13/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
06/16/2020
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/10/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/31/2020
PUBO
PUBLISHED FOR OPPOSITION
03/31/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/11/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/25/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/24/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/24/2020
ALIE
ASSIGNED TO LIE
02/20/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/13/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/26/2019
GNRT
NON-FINAL ACTION E-MAILED
08/26/2019
CNRT
NON-FINAL ACTION WRITTEN
08/26/2019
DOCK
ASSIGNED TO EXAMINER
08/24/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/22/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/21/2019
NWAP
NEW APPLICATION ENTERED
06/11/2019
Continuous trademark protection
Get notified about every new filing that threatens S SONORANT THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.